Ling Wang

2 ta ish

National Institutes for Food and Drug Control

1. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

   Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan +18

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.561376

2. micro<scp>RNA</scp>‐762 promotes breast cancer cell proliferation and invasion by targeting <scp>IRF</scp>7 expression

   Yongping Li, Ruixue Huang, Ling Wang +4

   Maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.816477